Rheumatoid Arthritis Market is expected to increase from $56.6 billio Rheumatoid Arthritis Market 2020 | Page 7

6.3 North America 72
6.3.1 Treatment Usage Patterns 72
6.3.2 Annual Cost of Therapy 72
6.3.3 Market Size 74
6.4 Top-Five EU Markets 75
6.4.1 Treatment Usage Patterns 75
6.4.2 Annual Cost of Therapy 76
6.4.3 Market Size 77
6.5 Japan 78
6.5.1 Treatment Usage Patterns 78
6.5.2 Annual Cost of Therapy 78
Read Complete Report with TOC @ http://www.radiantinsights.com/research/rheumatoidarthritis-market-to-2020-a-crowded-market-characterized-by-modest-growth
6.5.3 Market Size 79
6.6 Drivers and Barriers of Rheumatoid Arthritis Therapeutic Market 79
6.6.1 Drivers 79
6.6.2 Barriers 80

7 Deals and Strategic Consolidations 81
7.1 Licensing agreements 81
7.1.1 Deal Values by Therapeutic Molecule Types 83
7.1.2 Deal Values by Therapeutic mechanism of administration 85
7.1.3 AstraZeneca Enters into Licensing Agreement with Rigel Pharma for fostamatinib disodium 87
7.1.4 Alder Biopharmaceuticals Enters into Licensing Deal with Bristol-Myers Squibb Company Alder
Biopharmaceuticals for Clazakizumab 87
7.1.5 Janssen Biotech enters into a licensing deal with Astellas Pharma for Peficitinib 87